Essential role of TRPC1 channels in cardiomyoblasts hypertrophy mediated by 5-HT2A serotonin receptors

Biochemical and Biophysical Research Communications

Volumn 391, Issue 1, 2010, Pages 979-983

  Vindis, Cécile ^a   D'Angelo, Romina ^b   Mucher, Elodie ^a   Nègre Salvayre, Anne ^a   Parini, Angelo ^a   Mialet Perez, Jeanne ^a  

^a INSERM   (France)

^b CHU RANGUEIL   (France)

Author keywords

5 HT; 5 HT2A receptors; Cardiac hypertrophy; NFAT; TRPC

Indexed keywords

CALCINEURIN; CALCIUM ION; SEROTONIN; SEROTONIN 2A RECEPTOR; SMALL INTERFERING RNA; TRANSCRIPTION FACTOR NFAT; TRANSIENT RECEPTOR POTENTIAL CHANNEL 1; TRANSIENT RECEPTOR POTENTIAL CHANNEL 6;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CALCIUM CELL LEVEL; CHANNEL GATING; CONTROLLED STUDY; EMBRYO; ENZYME INACTIVATION; ENZYME INHIBITION; GENE SILENCING; HEART VENTRICLE HYPERTROPHY; MALE; MOUSE; MYOBLAST; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN INDUCTION; RAT; RECEPTOR BINDING; RNA INTERFERENCE; TRANSCRIPTION INITIATION; TRANSCRIPTION REGULATION; UPREGULATION;

ANIMALS; CARDIOMEGALY; CELL LINE; DISEASE MODELS, ANIMAL; GENE KNOCKDOWN TECHNIQUES; MALE; MICE; MICE, INBRED STRAINS; MYOBLASTS, CARDIAC; NFATC TRANSCRIPTION FACTORS; RATS; RECEPTOR, SEROTONIN, 5-HT2A; RNA, SMALL INTERFERING; SEROTONIN; TRPC CATION CHANNELS;

RATTUS;

EID: 73149118475     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2009.12.001     Document Type: Article

References (22)

1. Nigmatullina R.R., Kirillova V.V., Jourjikiya R.K., Mukhamedyarov M.A., Kudrin V.S., Klodt P.M., and Palotas A. Disrupted serotonergic and sympathoadrenal systems in patients with chronic heart failure may serve as new therapeutic targets and novel biomarkers to assess severity, progression and response to treatment. Cardiology 113 (2009) 277-286
2. Chandra M., Gupta V., Johri A.K., Misra R., Kumar A., Gujrati V., and Shanker K. Serotonergic mechanisms in heart failure. Indian Heart J. 46 (1994) 153-156
3. Brattelid T., Qvigstad E., Birkeland J.A., Swift F., Bekkevold S.V., Krobert K.A., Sejersted O.M., Skomedal T., Osnes J.B., Levy F.O., and Sjaastad I. Serotonin responsiveness through 5-HT2A and 5-HT4 receptors is differentially regulated in hypertrophic and failing rat cardiac ventricle. J. Mol. Cell. Cardiol. 43 (2007) 767-779
4. Cobo C., Alcocer L., and Chavez A. Effects of ketanserin on left ventricular hypertrophy in hypertensive patients. Cardiovasc. Drugs Ther. 4 Suppl. 1 (1990) 73-76
5. Lairez O., Calise D., Bianchi P., Ordener C., Spreux-Varoquaux O., Guilbeau-Frugier C., Escourrou G., Seif I., Roncalli J., Pizzinat N., Galinier M., Parini A., and Mialet-Perez J. Genetic deletion of MAO-A promotes serotonin-dependent ventricular hypertrophy by pressure overload. J. Mol. Cell. Cardiol. 46 (2009) 587-595
6. Villeneuve C., Caudrillier A., Ordener C., Pizzinat N., Parini A., and Mialet-Perez J. Dose-dependent activation of distinct hypertrophic pathways by serotonin in cardiac cells. Am. J. Physiol. Heart Circ. Physiol. 297 (2009) H821-H828
7. Bush E., Fielitz J., Melvin L., Martinez-Arnold M., McKinsey T.A., Plichta R., and Olson E.N. A small molecular activator of cardiac hypertrophy uncovered in a chemical screen for modifiers of the calcineurin signaling pathway. Proc. Natl. Acad. Sci. USA 101 (2004) 2870-2875
8. Wilkins B.J., Dai Y.S., Bueno O.F., Parsons S.A., Xu J., Plank D.M., Jones F., Kimball T.R., and Molkentin J.D. Calcineurin/NFAT coupling participates in pathological, but not physiological, cardiac hypertrophy. Circ. Res. 94 (2004) 110-118
9. Watanabe H., Murakami M., Ohba T., Takahashi Y., and Ito H. TRP channel and cardiovascular disease. Pharmacol. Ther. 118 (2008) 337-351
10. Beech D.J. Emerging functions of 10 types of TRP cationic channel in vascular smooth muscle. Clin. Exp. Pharmacol. Physiol. 32 (2005) 597-603
11. Bush E.W., Hood D.B., Papst P.J., Chapo J.A., Minobe W., Bristow M.R., Olson E.N., and McKinsey T.A. Canonical transient receptor potential channels promote cardiomyocyte hypertrophy through activation of calcineurin signaling. J. Biol. Chem. 281 (2006) 33487-33496
12. Nakayama H., Wilkin B.J., Bodi I., and Molkentin J.D. Calcineurin-dependent cardiomyopathy is activated by TRPC in the adult mouse heart. FASEB J. 20 (2006) 1660-1670
13. Onohara N., Nishida M., Inoue R., Kobayashi H., Sumimoto H., Sato Y., Mori Y., Nagao T., and Kurose H. TRPC3 and TRPC6 are essential for angiotensin II-induced cardiac hypertrophy. EMBO J. 25 (2006) 5305-5316
14. Kuwahara K., Wang Y., McAnally J., Richardson J.A., Bassel-Duby R., Hill J.A., and Olson E.N. TRPC6 fulfills a calcineurin signaling circuit during pathologic cardiac remodeling. J. Clin. Invest. 116 (2006) 3114-3126
15. Ohba T., Watanabe H., Murakami M., Takahashi Y., Iino K., Kuromitsu S., Mori Y., Ono K., Iijima T., and Ito H. Upregulation of TRPC1 in the development of cardiac hypertrophy. J. Mol. Cell. Cardiol. 42 (2007) 498-507
16. Johns D.G., Ao Z., Naselsky D., Herold C.L., Maniscalco K., Sarov-Blat L., Steplewski K., Aiyar N., and Douglas S.A. Urotensin-II-mediated cardiomyocyte hypertrophy: effect of receptor antagonism and role of inflammatory mediators. Naunyn Schmiedebergs Arch. Pharmacol. 370 (2004) 238-250
17. Stuck B.J., Lenski M., Bohm M., and Laufs U. Metabolic switch and hypertrophy of cardiomyocytes following treatment with angiotensin II are prevented by AMP-activated protein kinase. J. Biol. Chem. 283 (2008) 32562-32569
18. Nishida M., and Kurose H. Roles of TRP channels in the development of cardiac hypertrophy. Naunyn Schmiedebergs Arch. Pharmacol. 378 (2008) 395-406
19. Bianchi P., Pimentel D.R., Murphy M.P., Colucci W.S., and Parini A. A new hypertrophic mechanism of serotonin in cardiac myocytes: receptor-independent ROS generation. FASEB J. 19 (2005) 641-643
20. Seth M., Zhang Z.S., Mao L., Graham V., Burch J., Stiber J., Tsiokas L., Winn M., Abramowitz J., Rockman H.A., Birnbaumer L., and Rosenberg P. TRPC1 channels are critical for hypertrophic signaling in the heart. Circ. Res. 105 (2009) 1023-1030
21. Niizeki T., Takeishi Y., Kitahara T., Arimoto T., Ishino M., Bilim O., Suzuki S., Sasaki T., Nakajima O., Walsh R.A., Goto K., and Kubota I. Diacylglycerol kinase-epsilon restores cardiac dysfunction under chronic pressure overload: a new specific regulator of Galpha(q) signaling cascade. Am. J. Physiol. Heart Circ. Physiol. 295 (2008) H245-H255
22. Hofmann T., Schaefer M., Schultz G., and Gudermann T. Subunit composition of mammalian transient receptor potential channels in living cells. Proc. Natl. Acad. Sci. USA 99 (2002) 7461-7466